Webinar Recording: How to use TPMT and NUDT15 PGx to Reduce Thiopurines-related Adverse Reactions
Presenters: Dr. Gunter Scharer
Recording Date: September 26, 2019
Contact Us
PGx at Boston Children's Hospital
Dr. Shannon Manzi discusses how TPMT and NUDT15 pharmacogenetics help Boston Children’s Hospital reduce thiopurines-related toxicity and overall cost of care.
Insight into TPMT and NUDT15
Learn more about how TPMT and NUDT15 variants lead to thiopurines-induced toxicity and how to use pharmacogentics to reduce the adverse reactions.
Resources
Learn more about pharmacogenetics using our educational resources.